Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn Velligan

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Psychiatric Services (Washington, D.C.)|October 5, 2022
Remote Cognitive Adaptation Training During and After COVID-19Dawn Velligan, Frankie Lara, Feiyu Li
Schizophrenia Bulletin|August 1, 2024
Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future OpportunitiesKeith H Nuechterlein, Henry Nasrallah, Dawn Velligan
Clinical Schizophrenia & Related Psychoses|November 5, 2014
The Long-Term Effects of Cellular Telephone-Delivered Telephone Intervention Problem Solving (TIPS) for Schizophrenia Spectrum Disorders (SSDs): Rationale and DesignLora H Beebe, Kathlene Smith, Chad Phillips, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2024
Relationship between social determinants of health and hospitalizations and costs in patients with major depressive disorderChristie Teigland, Iman Mohammadi, Barnabie C Agatep, et al.
Schizophrenia Research|May 1, 2013
Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophreniaConsuelo Walss-Bass, João M Fernandes, David L Roberts, et al.
Schizophrenia Bulletin|October 23, 2012
A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophreniaDawn Velligan, Jim Mintz, Natalie Maples, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 17, 2018
Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophreniaGiselli Scaini, João Quevedo, Dawn Velligan, et al.
Psychiatric Services (Washington, D.C.)|October 31, 2008
Public-academic partnerships: research in community mental health settings: a practicum experience for researchersAlexander L Miller, Linda Lopez, Jodi M Gonzalez, et al.
Journal of the American Psychiatric Nurses Association|May 7, 2010
Effect of a motivational group intervention upon exercise self efficacy and outcome expectations for exercise in Schizophrenia Spectrum Disorders (SSDs)Lora Humphrey Beebe, Kathlene Smith, Renee Burk, et al.
Journal of the American Psychiatric Nurses Association|June 11, 2011
Effect of a motivational group intervention on exercise self-efficacy and outcome expectations for exercise in schizophrenia spectrum disordersLora Humphrey Beebe, Kathlene Smith, Renee Burk, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Psychiatric Services (Washington, D.C.)|October 5, 2022
Remote Cognitive Adaptation Training During and After COVID-19Dawn Velligan, Frankie Lara, Feiyu Li
Schizophrenia Bulletin|August 1, 2024
Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future OpportunitiesKeith H Nuechterlein, Henry Nasrallah, Dawn Velligan
Clinical Schizophrenia & Related Psychoses|November 5, 2014
The Long-Term Effects of Cellular Telephone-Delivered Telephone Intervention Problem Solving (TIPS) for Schizophrenia Spectrum Disorders (SSDs): Rationale and DesignLora H Beebe, Kathlene Smith, Chad Phillips, et al.
Journal of Managed Care & Specialty Pharmacy|August 30, 2024
Relationship between social determinants of health and hospitalizations and costs in patients with major depressive disorderChristie Teigland, Iman Mohammadi, Barnabie C Agatep, et al.
Schizophrenia Research|May 1, 2013
Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophreniaConsuelo Walss-Bass, João M Fernandes, David L Roberts, et al.
Schizophrenia Bulletin|October 23, 2012
A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophreniaDawn Velligan, Jim Mintz, Natalie Maples, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 17, 2018
Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophreniaGiselli Scaini, João Quevedo, Dawn Velligan, et al.
Psychiatric Services (Washington, D.C.)|October 31, 2008
Public-academic partnerships: research in community mental health settings: a practicum experience for researchersAlexander L Miller, Linda Lopez, Jodi M Gonzalez, et al.
Journal of the American Psychiatric Nurses Association|May 7, 2010
Effect of a motivational group intervention upon exercise self efficacy and outcome expectations for exercise in Schizophrenia Spectrum Disorders (SSDs)Lora Humphrey Beebe, Kathlene Smith, Renee Burk, et al.
Journal of the American Psychiatric Nurses Association|June 11, 2011
Effect of a motivational group intervention on exercise self-efficacy and outcome expectations for exercise in schizophrenia spectrum disordersLora Humphrey Beebe, Kathlene Smith, Renee Burk, et al.
Pageof 4